Congress Instructs FDA On Nanotech Work, But Mum On Regulations

The recently passed user fee reauthorization includes a provision that directs FDA to evaluate nano-engineered products’ potential benefits and safety. Friends of the Earth says nanotech products are available “prematurely … without having enough safety data.”

More from United States

More from North America